Geode Capital Management’s Viridian Therapeutics VRDN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.3M | Buy |
1,740,614
+20,089
| +1% | +$281K | ﹤0.01% | 1859 |
|
|
2025
Q1 | $23.2M | Buy |
1,720,525
+61,545
| +4% | +$830K | ﹤0.01% | 1823 |
|
|
2024
Q4 | $31.8M | Buy |
1,658,980
+165,669
| +11% | +$3.18M | ﹤0.01% | 1699 |
|
|
2024
Q3 | $34M | Buy |
1,493,311
+81,951
| +6% | +$1.86M | ﹤0.01% | 1673 |
|
|
2024
Q2 | $18.4M | Buy |
1,411,360
+247,088
| +21% | +$3.22M | ﹤0.01% | 1975 |
|
|
2024
Q1 | $20.4M | Buy |
1,164,272
+169,804
| +17% | +$2.97M | ﹤0.01% | 1912 |
|
|
2023
Q4 | $21.7M | Buy |
994,468
+135,373
| +16% | +$2.95M | ﹤0.01% | 1860 |
|
|
2023
Q3 | $13.2M | Sell |
859,095
-1,762
| -0.2% | -$27K | ﹤0.01% | 2086 |
|
|
2023
Q2 | $20.5M | Buy |
860,857
+84,745
| +11% | +$2.02M | ﹤0.01% | 1841 |
|
|
2023
Q1 | $19.7M | Buy |
776,112
+65,127
| +9% | +$1.66M | ﹤0.01% | 1812 |
|
|
2022
Q4 | $20.8M | Buy |
710,985
+111,219
| +19% | +$3.25M | ﹤0.01% | 1751 |
|
|
2022
Q3 | $12.3M | Buy |
599,766
+150,106
| +33% | +$3.08M | ﹤0.01% | 2088 |
|
|
2022
Q2 | $5.2M | Buy |
449,660
+250,422
| +126% | +$2.9M | ﹤0.01% | 2678 |
|
|
2022
Q1 | $3.68M | Sell |
199,238
-2,440
| -1% | -$45.1K | ﹤0.01% | 2961 |
|
|
2021
Q4 | $3.99M | Buy |
201,678
+140,428
| +229% | +$2.78M | ﹤0.01% | 3020 |
|
|
2021
Q3 | $1.01M | Buy |
61,250
+22,967
| +60% | +$378K | ﹤0.01% | 3671 |
|
|
2021
Q2 | $700K | Buy |
38,283
+15,389
| +67% | +$281K | ﹤0.01% | 3777 |
|
|
2021
Q1 | $382K | Buy |
22,894
+7,219
| +46% | +$120K | ﹤0.01% | 3900 |
|
|
2020
Q4 | $257K | Sell |
15,675
-247,695
| -94% | -$4.06M | ﹤0.01% | 3808 |
|
|
2020
Q3 | $204K | Buy |
263,370
+87,030
| +49% | +$67.4K | ﹤0.01% | 3711 |
|
|
2020
Q2 | $195K | Buy |
176,340
+21,621
| +14% | +$23.9K | ﹤0.01% | 3670 |
|
|
2020
Q1 | $69K | Hold |
154,719
| – | – | ﹤0.01% | 3859 |
|
|
2019
Q4 | $74K | Hold |
154,719
| – | – | ﹤0.01% | 4026 |
|
|
2019
Q3 | $113K | Sell |
154,719
-1,141
| -0.7% | -$833 | ﹤0.01% | 3921 |
|
|
2019
Q2 | $319K | Sell |
155,860
-85,404
| -35% | -$175K | ﹤0.01% | 3632 |
|
|
2019
Q1 | $673K | Buy |
241,264
+11,137
| +5% | +$31.1K | ﹤0.01% | 3313 |
|
|
2018
Q4 | $697K | Buy |
230,127
+11,541
| +5% | +$35K | ﹤0.01% | 3247 |
|
|
2018
Q3 | $1.22M | Buy |
218,586
+9,467
| +5% | +$52.8K | ﹤0.01% | 3132 |
|
|
2018
Q2 | $1.34M | Buy |
209,119
+107,492
| +106% | +$689K | ﹤0.01% | 3060 |
|
|
2018
Q1 | $712K | Buy |
101,627
+9,145
| +10% | +$64.1K | ﹤0.01% | 3278 |
|
|
2017
Q4 | $964K | Buy |
92,482
+8,080
| +10% | +$84.2K | ﹤0.01% | 3119 |
|
|
2017
Q3 | $772K | Buy |
84,402
+53,576
| +174% | +$490K | ﹤0.01% | 3209 |
|
|
2017
Q2 | $398K | Buy |
30,826
+18,868
| +158% | +$244K | ﹤0.01% | 3435 |
|
|
2017
Q1 | $148K | Buy |
+11,958
| New | +$148K | ﹤0.01% | 3740 |
|